Free Trial

Smith & Nephew plc (LON:SN) Insider Purchases £699,062.40 in Stock

Smith & Nephew logo with Medical background

Smith & Nephew plc (LON:SN - Get Free Report) insider John Rogers purchased 71,920 shares of the company's stock in a transaction dated Thursday, December 19th. The stock was purchased at an average price of GBX 972 ($12.15) per share, for a total transaction of £699,062.40 ($873,718.79).

Smith & Nephew Stock Down 0.3 %

SN traded down GBX 3.40 ($0.04) during trading on Friday, hitting GBX 977.20 ($12.21). The company's stock had a trading volume of 1,777,711 shares, compared to its average volume of 343,671. The stock has a market capitalization of £8.52 billion, a price-to-earnings ratio of 3,619.26, a P/E/G ratio of 0.46 and a beta of 0.62. The business's fifty day simple moving average is GBX 1,014.11 and its two-hundred day simple moving average is GBX 1,074.82. The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84.

Smith & Nephew Company Profile

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Read More

Should you invest $1,000 in Smith & Nephew right now?

Before you consider Smith & Nephew, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.

While Smith & Nephew currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines